Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	73
Overall Study	STARTED	Perampanel 2mg	72
Overall Study	STARTED	Perampanel 4mg	69
Overall Study	STARTED	Perampanel 6mg	68
Overall Study	STARTED	Perampanel 8mg	70
Overall Study	COMPLETED	Placebo	63
Overall Study	COMPLETED	Perampanel 2mg	56
Overall Study	COMPLETED	Perampanel 4mg	57
Overall Study	COMPLETED	Perampanel 6mg	49
Overall Study	COMPLETED	Perampanel 8mg	37
Overall Study	NOT COMPLETED	Placebo	10
Overall Study	NOT COMPLETED	Perampanel 2mg	16
Overall Study	NOT COMPLETED	Perampanel 4mg	12
Overall Study	NOT COMPLETED	Perampanel 6mg	19
Overall Study	NOT COMPLETED	Perampanel 8mg	33

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00505284/flow